PL353449A1 - Środek farmaceutyczny zawierający pochodną benzamidu jako składnik czynny - Google Patents

Środek farmaceutyczny zawierający pochodną benzamidu jako składnik czynny

Info

Publication number
PL353449A1
PL353449A1 PL00353449A PL35344900A PL353449A1 PL 353449 A1 PL353449 A1 PL 353449A1 PL 00353449 A PL00353449 A PL 00353449A PL 35344900 A PL35344900 A PL 35344900A PL 353449 A1 PL353449 A1 PL 353449A1
Authority
PL
Poland
Prior art keywords
active ingredient
pharmaceutical agent
benzamide derivative
benzamide
derivative
Prior art date
Application number
PL00353449A
Other languages
English (en)
Other versions
PL201388B1 (pl
Inventor
Tsuneji Suzuki
Tomoyuki Ando
Masahiko Ishibashi
Masahiro Sakabe
Ikuo Sakai
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of PL353449A1 publication Critical patent/PL353449A1/pl
Publication of PL201388B1 publication Critical patent/PL201388B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL353449A 1999-08-16 2000-08-16 Preparaty farmaceutyczne w postaci stałej lub ciekłej zawierające pochodną benzamidu jako substancję czynną PL201388B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22955199A JP2001064177A (ja) 1999-08-16 1999-08-16 ベンズアミド誘導体を有効成分とする製剤
PCT/EP2000/008011 WO2001012193A1 (en) 1999-08-16 2000-08-16 Pharmaceutical agent comprising a benzamide derivative as active ingredient

Publications (2)

Publication Number Publication Date
PL353449A1 true PL353449A1 (pl) 2003-11-17
PL201388B1 PL201388B1 (pl) 2009-04-30

Family

ID=16893948

Family Applications (1)

Application Number Title Priority Date Filing Date
PL353449A PL201388B1 (pl) 1999-08-16 2000-08-16 Preparaty farmaceutyczne w postaci stałej lub ciekłej zawierające pochodną benzamidu jako substancję czynną

Country Status (29)

Country Link
EP (1) EP1207881B1 (pl)
JP (2) JP2001064177A (pl)
KR (1) KR100683876B1 (pl)
CN (1) CN1205931C (pl)
AR (1) AR031074A1 (pl)
AU (1) AU780151B2 (pl)
BG (1) BG65662B1 (pl)
BR (1) BR0013283A (pl)
CA (1) CA2380757C (pl)
CY (1) CY1116273T1 (pl)
CZ (1) CZ302924B6 (pl)
DK (1) DK1207881T3 (pl)
EE (1) EE05331B1 (pl)
ES (1) ES2536705T3 (pl)
HK (1) HK1046501B (pl)
HR (1) HRP20020181B1 (pl)
HU (1) HU230386B1 (pl)
IL (1) IL148169A0 (pl)
MX (1) MXPA02001575A (pl)
NO (1) NO328957B1 (pl)
NZ (1) NZ517356A (pl)
PL (1) PL201388B1 (pl)
PT (1) PT1207881E (pl)
RU (1) RU2257206C2 (pl)
SK (1) SK287547B6 (pl)
TW (1) TWI245630B (pl)
UA (1) UA73316C2 (pl)
WO (1) WO2001012193A1 (pl)
ZA (1) ZA200201466B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001081031A (ja) * 1999-08-30 2001-03-27 Schering Ag 溶解性および経口吸収性を改善したベンズアミド誘導体含有製剤
WO2002024230A1 (en) * 2000-09-22 2002-03-28 Takeda Chemical Industries, Ltd. Solid preparations
US7566535B2 (en) 2002-03-07 2009-07-28 University Of Delaware Enhanced oligonucleotide-mediated nucleic acid sequence alteration
GB0316206D0 (en) 2003-07-10 2003-08-13 Glaxo Group Ltd Pharmaceutical formulation
WO2008123395A1 (ja) 2007-03-28 2008-10-16 Santen Pharmaceutical Co., Ltd. ヒストン脱アセチル化酵素阻害作用を有する化合物を有効成分として含有する眼圧下降剤
KR101405615B1 (ko) * 2007-08-27 2014-06-12 (주)아모레퍼시픽 조성물 내 ｐＨ 조절을 통해 안정화된 벤즈아미드 화합물을함유하는 피부 외용제 조성물, 및 그 벤즈아미드 화합물안정화 방법
RS52164B (sr) * 2008-08-29 2012-08-31 Bayer Pharma Aktiengesellschaft N-(2-aminofenil)-4-[n-(piridin-3-il)-metoksikarbonilaminometil]-benzamid (ms-275)polimorf b
GB2462893B (en) * 2008-08-29 2010-10-13 Bayer Schering Pharma Ag N-(2-aminophenyl)-4-[N-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (MS-275) polymorph B
BR112014029538B1 (pt) * 2013-04-04 2022-07-05 Daiichi Sankyo Company, Limited Composição farmacêutica sólida
US10561628B2 (en) 2015-03-19 2020-02-18 Daiichi Sankyo Company, Limited Solid preparation including antioxidant
BR112017019920B1 (pt) 2015-03-19 2023-11-07 Daiichi Sankyo Company, Limited Preparação sólida farmacêutica, e, método para estabilização de uma preparação sólida farmacêutica
JP7312751B2 (ja) 2018-07-30 2023-07-21 第一三共株式会社 安定化剤を含有する医薬品の固形製剤
WO2020153520A1 (ko) * 2019-01-25 2020-07-30 (주)아모레퍼시픽 벤조산아마이드 화합물 및 용해보조제를 포함하는 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU706415A1 (ru) * 1978-04-12 1979-12-30 Ташкентский Государственный Университет Им.В.И.Ленина Итаконоил анабазин в качестве дыхательного аналептика
CZ284687B6 (cs) * 1986-04-30 1999-02-17 Dainippon Pharmaceutical Co., Ltd. Substituovaný benzamidový derivát, způsob jeho výroby a farmaceutický prostředek na jeho bázi
US6174905B1 (en) * 1996-09-30 2001-01-16 Mitsui Chemicals, Inc. Cell differentiation inducer
JP3354090B2 (ja) * 1996-09-30 2002-12-09 シエーリング アクチエンゲゼルシャフト 分化誘導剤

Also Published As

Publication number Publication date
AR031074A1 (es) 2003-09-10
BG65662B1 (bg) 2009-05-29
BR0013283A (pt) 2002-04-23
NO328957B1 (no) 2010-06-28
SK2092002A3 (en) 2002-07-02
EP1207881A1 (en) 2002-05-29
IL148169A0 (en) 2002-09-12
TWI245630B (en) 2005-12-21
SK287547B6 (sk) 2011-01-04
EE05331B1 (et) 2010-08-16
RU2257206C2 (ru) 2005-07-27
JP4854158B2 (ja) 2012-01-18
CZ302924B6 (cs) 2012-01-18
KR100683876B1 (ko) 2007-02-15
CA2380757C (en) 2009-01-27
HK1046501A1 (en) 2003-01-17
HUP0203226A2 (hu) 2003-01-28
NO20020774D0 (no) 2002-02-15
CA2380757A1 (en) 2001-02-22
JP2001064177A (ja) 2001-03-13
MXPA02001575A (es) 2003-10-14
HU230386B1 (hu) 2016-03-29
PT1207881E (pt) 2015-06-05
ZA200201466B (en) 2002-09-02
AU780151B2 (en) 2005-03-03
KR20020020815A (ko) 2002-03-15
NO20020774L (no) 2002-03-04
HRP20020181B1 (hr) 2016-01-29
CN1370068A (zh) 2002-09-18
DK1207881T3 (da) 2015-06-22
HK1046501B (zh) 2005-09-30
JP2003507330A (ja) 2003-02-25
CY1116273T1 (el) 2017-02-08
HRP20020181A2 (en) 2005-10-31
ES2536705T3 (es) 2015-05-27
NZ517356A (en) 2003-07-25
WO2001012193A1 (en) 2001-02-22
RU2002106815A (ru) 2004-01-27
CZ2002540A3 (cs) 2002-06-12
HUP0203226A3 (en) 2003-12-29
BG106516A (en) 2002-10-31
EE200200073A (et) 2003-04-15
AU6442700A (en) 2001-03-13
EP1207881B1 (en) 2015-04-01
UA73316C2 (uk) 2005-07-15
CN1205931C (zh) 2005-06-15
PL201388B1 (pl) 2009-04-30

Similar Documents

Publication Publication Date Title
IL148357A0 (en) Pharmaceutical compositions containing a benzamide derivative
HUP0401963A3 (en) Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient
PL351526A1 (en) Pharmaceutical formulation comprising amoxycillin
AU3076700A (en) 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient
PL372084A1 (pl) Związek pochodnej 8-azaprostaglandyny i środek zawierający ten związek jako składnik aktywny
IL164699A0 (en) Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
HRP20020181A2 (en) Pharmaceutical agent comprising a benzamide derivative as active ingredient
PT1200118E (pt) Formulação farmacêutica compreendendo melagatrano e seu pró-fármaco
HUP0303636A3 (en) Dihydronaphthalenederivative compounds and pharmaceutical compositions containing them as active ingredient
HUP0303860A3 (en) A pharmaceutical tablet having a high active ingredient
GB9924992D0 (en) Pharmaceutical aerosol formulations
GB9909154D0 (en) Pharmaceutical formulation
IL161166A0 (en) Solid pharmaceutical formulation for a piperazine urea derivative
GB9926251D0 (en) Pharmaceutical formulation
IL161768A0 (en) Carboxylic acid derivative compounds and drugs containing the same as the active ingredient
AU2002225349B2 (en) Dihydronaphthalene derivative compounds and drugs containing these compounds as the active ingredient
GB9921289D0 (en) Pharmaceutical aerosol formulation
PL366298A1 (pl) Stabilny preparat farmaceutyczny zawierający modyfikację II torsemidu
AU2002225349A1 (en) Dihydronaphthalene derivative compounds and drugs containing these compounds as the active ingredient
GB9917775D0 (en) Pharmaceutical formulation
GB9927685D0 (en) Pharmaceutical formulation
GB9910636D0 (en) Pharmaceutical formulation
GB9917777D0 (en) Pharmaceutical formulation
GB9910633D0 (en) Pharmaceutical formulation
GB9922187D0 (en) Pharmaceutical formulation